[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Erasca Inc (ERAS)

Erasca Inc (ERAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,942,923
  • Shares Outstanding, K 310,985
  • Annual Sales, $ 0 K
  • Annual Income, $ -124,550 K
  • EBIT $ -293 M
  • EBITDA $ -295 M
  • 60-Month Beta 0.66
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 15.28

Options Overview Details

View History
  • Implied Volatility 104.93% (+1.00%)
  • Historical Volatility 78.43%
  • IV Percentile 25%
  • IV Rank 7.93%
  • IV High 404.74% on 09/16/25
  • IV Low 79.11% on 05/19/26
  • Expected Move (DTE 27) 1.74 (9.12%)
  • Put/Call Vol Ratio 0.56
  • Today's Volume 765
  • Volume Avg (30-Day) 6,531
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 148,993
  • Open Int (30-Day) 150,783
  • Expected Range 17.37 to 20.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 6
  • High Estimate $-0.11
  • Low Estimate $-0.13
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.44 +32.29%
on 06/25/26
21.60 -11.53%
on 07/15/26
+4.06 (+26.98%)
since 06/24/26
3-Month
8.70 +119.66%
on 04/28/26
21.67 -11.79%
on 04/27/26
-2.38 (-11.07%)
since 04/24/26
52-Week
1.33 +1,336.73%
on 09/03/25
24.28 -21.29%
on 04/23/26
+17.40 (+1,017.54%)
since 07/24/25

Most Recent Stories

More News
Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS

NEW ORLEANS , July 24, 2026 /PRNewswire/ -- ClaimsFiler , a FREE shareholder information service, reminds investors that they have until August 10, 2026  to file lead plaintiff applications...

ERAS : 19.11 (-1.19%)
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors...

ERAS : 19.11 (-1.19%)
Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , July 24, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ERAS : 19.11 (-1.19%)
ERAS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO , July 24, 2026 /PRNewswire/ -- The law firm of  Robbins Geller Rudman & Dowd LLP  announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between...

ERAS : 19.11 (-1.19%)
ERAS Investor Alert: HBSS Investigating Pending Claims Against Erasca (ERAS) in Securities Class Action Arising from Patent Litigation and Patient Safety Risks

SAN FRANCISCO , July 24, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc....

ERAS : 19.11 (-1.19%)
Lost Money on Erasca, Inc. (ERAS)? Join Class Action Suit Seeking Recovery - Contact SueWallSt

Critical Information: ERAS Investors Lost $11.59 Per Share as Artificially Inflated Stock Price Collapsed Following Dual Corrective Disclosures on April 27-28, 2026

ERAS : 19.11 (-1.19%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming Deadlines - ERAS

NEW YORK , July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS).   Such investors...

ERAS : 19.11 (-1.19%)
ERAS INVESTOR DEADLINE: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - HBSS

SAN FRANCISCO , July 23, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc....

ERAS : 19.11 (-1.19%)
Kaplan Fox & Kilsheimer LLP Encourages Erasca, Inc. (NASDAQ: ERAS) Investors to Contact the Firm Before August 10, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ERAS : 19.11 (-1.19%)
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

NEW YORK , July 22, 2026 /PRNewswire/ -- 

ERAS : 19.11 (-1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 20.37
2nd Resistance Point 20.09
1st Resistance Point 19.60
Last Price 19.11
1st Support Level 18.83
2nd Support Level 18.56
3rd Support Level 18.07

See More

52-Week High 24.28
Last Price 19.11
Fibonacci 61.8% 15.51
Fibonacci 50% 12.81
Fibonacci 38.2% 10.10
52-Week Low 1.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.